Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Baricitinib is effective and safe for treating severe alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Rituximab can cause skin issues, but baricitinib may help improve them.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Combining PRP with hydroquinone is more effective for treating melasma than using hydroquinone alone.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.